Gregory Leighton
About Gregory Leighton
Gregory Leighton serves as the Vice President of Access Strategies and Patient Services at Ardelyx, Inc., where he utilizes technology solutions to improve the patient experience. He has extensive experience in patient access services, having held various leadership roles at Asembia and Walgreens Boots Alliance.
Work at Ardelyx
Gregory Leighton serves as the Vice President of Access Strategies and Patient Services at Ardelyx, Inc. since 2021. In this role, he leverages technology solutions such as electronic prior authorizations and real-time prescription benefits to enhance the patient journey. He previously held the position of Director of Patient Services at Ardelyx from 2020 to 2021. His current responsibilities include overseeing the development of specialty pharmacy networks and implementing patient assistance solutions.
Previous Experience at Asembia
Prior to his role at Ardelyx, Gregory Leighton worked at Asembia in various capacities. He served as Director of Clinical Operations (Patient Access Services) from 2016 to 2017, and later as Senior Director of Clinical Patient Support Operations and Compliance (Patient Access Services) from 2017 to 2019. He also held the position of Vice President of Clinical Solutions & Patient Access from 2019 to 2020. His experience at Asembia focused on patient access services and operational management.
Pharmacy Experience at Walgreens Boots Alliance
Gregory Leighton has significant experience in pharmacy operations, having worked at Walgreens Boots Alliance. He was a Clinical Staff Pharmacist at the HIV Center of Excellence Pharmacy from 2011 to 2012 and later served as Supervising Pharmacist from 2012 to 2015. He also worked as a Clinical Onsite Pharmacy Supervisor and Registered Store Manager from 2015 to 2016. His roles involved overseeing pharmacy operations and patient care.
Education and Expertise
Gregory Leighton studied at St. John's University, where he earned a Doctorate of Pharmacy. His educational background supports his expertise in pharmacy and patient access strategies. He provides market and payer access strategies for various product categories, including specialty and rare/orphan therapies. Additionally, he serves as a speaker at industry engagements and conferences, sharing insights on patient support and reimbursement strategies.